Randomized clinical trial in 39 National Health Service hospitals in the United Kingdom ; 1202 eligible participants were recruited between January 2003 and August 2009 who had undergone curative surgery for primary colorectal cancer , including adjuvant treatment if indicated , with no evidence of residual disease on investigation .